Dr. Ting Tao of Dana-Farber Cancer Institute is working to understand the mechanisms of how cancerous neuroblastoma cells can turn into noncancerous ganglioneuroma cells.

Dr. Amanda Saratsis is Modifying the Future: Chromatin Modifications & Related Therapies for the Treatment of Pediatric Brain Tumors

Dr. Sakamoto is developing new therapies for relapsed acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

The state of the art research of Markus Müschen at City of Hope utilizes the Goldilocks concept to treat childhood B-cell leukemia.

Dr. Shulin Li improves the quality of life & survival rate of children with neuroblastoma by identifying relapse risk & monitoring maintenance therapy.

Dr. Crompton of Dana-Farber Cancer Institute focuses his research on finding new treatment approaches for patients with Ewing sarcoma.